ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 117 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,402 | -6.0% | 19,191 | +2.3% | 0.00% | – |
| Q2 2023 | $30,208 | -41.3% | 18,763 | +5.7% | 0.00% | – |
| Q1 2023 | $51,463 | -20.7% | 17,746 | -10.3% | 0.00% | – |
| Q4 2022 | $64,872 | -6.0% | 19,778 | +8.9% | 0.00% | – |
| Q3 2022 | $69,000 | -49.6% | 18,158 | +3.2% | 0.00% | – |
| Q2 2022 | $137,000 | -43.2% | 17,587 | -32.2% | 0.00% | -100.0% |
| Q1 2022 | $241,000 | -51.3% | 25,931 | -17.5% | 0.00% | 0.0% |
| Q4 2021 | $495,000 | -3.7% | 31,414 | +9.5% | 0.00% | 0.0% |
| Q3 2021 | $514,000 | -9.5% | 28,697 | -21.5% | 0.00% | -50.0% |
| Q2 2021 | $568,000 | +20.3% | 36,546 | +11.2% | 0.00% | +100.0% |
| Q1 2021 | $472,000 | -16.5% | 32,870 | +14.3% | 0.00% | -50.0% |
| Q4 2020 | $565,000 | +109.3% | 28,759 | +38.0% | 0.00% | +100.0% |
| Q3 2020 | $270,000 | -3.6% | 20,845 | +8.3% | 0.00% | 0.0% |
| Q2 2020 | $280,000 | +214.6% | 19,242 | +83.9% | 0.00% | 0.0% |
| Q1 2020 | $89,000 | -71.1% | 10,461 | -44.0% | 0.00% | 0.0% |
| Q4 2019 | $308,000 | +6.9% | 18,690 | -8.4% | 0.00% | -50.0% |
| Q3 2019 | $288,000 | -20.2% | 20,412 | +13.6% | 0.00% | 0.0% |
| Q2 2019 | $361,000 | -55.2% | 17,961 | -11.3% | 0.00% | -60.0% |
| Q1 2019 | $805,000 | +16.5% | 20,240 | +1.8% | 0.01% | 0.0% |
| Q4 2018 | $691,000 | -29.3% | 19,890 | -15.8% | 0.01% | -28.6% |
| Q3 2018 | $977,000 | +11.5% | 23,622 | -0.9% | 0.01% | +16.7% |
| Q2 2018 | $876,000 | +1.4% | 23,825 | +7.5% | 0.01% | 0.0% |
| Q1 2018 | $864,000 | +133.5% | 22,157 | +8.3% | 0.01% | +100.0% |
| Q4 2017 | $370,000 | +17.8% | 20,454 | +7.9% | 0.00% | 0.0% |
| Q3 2017 | $314,000 | +30.3% | 18,963 | +10.3% | 0.00% | +50.0% |
| Q2 2017 | $241,000 | -35.2% | 17,192 | -4.9% | 0.00% | -50.0% |
| Q1 2017 | $372,000 | +14.8% | 18,079 | -20.7% | 0.00% | 0.0% |
| Q4 2016 | $324,000 | -26.0% | 22,796 | +11.4% | 0.00% | -33.3% |
| Q3 2016 | $438,000 | -19.8% | 20,462 | -15.6% | 0.01% | -14.3% |
| Q2 2016 | $546,000 | +23.3% | 24,236 | +4.2% | 0.01% | +16.7% |
| Q1 2016 | $443,000 | -34.2% | 23,256 | -8.7% | 0.01% | -25.0% |
| Q4 2015 | $673,000 | – | 25,478 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 800,000 | $11,656,000 | 5.38% |
| Consonance Capital Management LP | 5,238,218 | $76,321,000 | 4.57% |
| BRIDGER MANAGEMENT, LLC | 1,785,784 | $26,019,000 | 2.41% |
| Trellus Management Company, LLC | 150,000 | $2,186,000 | 2.37% |
| MAVERICK CAPITAL LTD | 6,754,102 | $98,407,000 | 2.07% |
| Redmile Group, LLC | 6,843,370 | $99,708,000 | 1.84% |
| Baupost Group | 9,922,030 | $144,564,000 | 1.80% |
| Camber Capital Management LP | 1,400,000 | $20,398,000 | 1.17% |
| Pinz Capital Management, LP | 161,100 | $2,347,000 | 1.08% |
| Artal Group S.A. | 2,500,000 | $36,425,000 | 1.02% |